Abstracts & Posters 2023

P1	The impact of antiretroviral therapy on the gut-oral microbiome in HIV Infection, Narayanan et al.
P2	HIV healthcare provider perspectives on Patient Reported Outcome (PRO) use in Danish HIV care – A Qualitative focus group interview study, Borchmann et al.
P3	Extracutaneous Kaposi Sarcoma Risk Remains Higher in People with HIV in the Post-ART Era, Dinh et al.
P4
P5	Decentralized testing and treatment of hepatitis C in people who inject drugs – the Shared Addiction Care Collaboration (SACC) project, Sølund et al.
P6	The cascade of care for patients with chronic hepatitis delta in Southern Stockholm, Sweden for the past 30 years, Kamal et al.
P7	Prevalence of and odds for treatment failure by migrant status in people living with HIV in Sweden, Adlers et al.
P8	Implementation and evaluation of a multi-component workplace HIV testing intervention at construction workplaces in the UK, Blake et al.
P9
P10	The Nuc-Stop Study: an open-label, randomized trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B patients, Johannessen et al.
P11	Age and sex-specific risks for hepatocellular carcinoma in African-born persons with chronic hepatitis B without cirrhosis, Kamal et al.
P12	Real-world estimation of SARS-CoV-2 vaccination, infection and hospitalization by HIV-status: a population-based cohort study, Killander Möller at el.
P13	Sweden surpasses the UNAIDS 95-95-95 Target: Estimating HIV-1 incidence between 2003-2022, Lundgren et al.
P14	PADI4-mediated histone 3 citrullination contributes to HIV-1 latency reversal, Love et al.
P15
P16	Antiviral T cell immunity in HIV-infected children on long-term antiretroviral therapy, Olofsson et al.
P17	CEREBROSPINAL FLUID NFL DECREASES AFTER INITIATION OF ANTIRETROVIRAL TREATMENT, BUT SLOWER THAN INFLAMMATORY BIOMARKERS, Renborg et al.
P18	Characterization of Antiviral T cells in HIV infection, Ballesteros et al.
P19
O4	IR of Liver events by curent age in patients with chronic hepatitis B with (red) and without (blur) metabolic co-morbidities, Jespersen et al.